<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>NISCAIR Online Periodicals Repository Community: IJC-B Vol.51B [2012]</title>
    <link>http://nopr.niscair.res.in/handle/123456789/13374</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li resource="http://nopr.niscair.res.in/handle/123456789/15200" />
        <rdf:li resource="http://nopr.niscair.res.in/handle/123456789/15199" />
        <rdf:li resource="http://nopr.niscair.res.in/handle/123456789/15198" />
        <rdf:li resource="http://nopr.niscair.res.in/handle/123456789/15197" />
      </rdf:Seq>
    </items>
  </channel>
  <textInput>
    <title>The Community's search engine</title>
    <description>Search the Channel</description>
    <name>search</name>
    <link>http://nopr.niscair.res.in/simple-search</link>
  </textInput>
  <item rdf:about="http://nopr.niscair.res.in/handle/123456789/15200">
    <title>An efficient synthesis of lactarochromal from  6-amino-2,2-dimethylchroman-4-one</title>
    <link>http://nopr.niscair.res.in/handle/123456789/15200</link>
    <description>Title: An efficient synthesis of lactarochromal from  6-amino-2,2-dimethylchroman-4-one
&lt;br/&gt;
&lt;br/&gt;Authors: Kamat, Vijayendra P; Asolkar, Ratnakar N; Kirtany, Janardan K
&lt;br/&gt;
&lt;br/&gt;Abstract: Lactarochromal &lt;b style="mso-bidi-font-weight:normal"&gt;1&lt;/b&gt;, a metabolite of &lt;i style="mso-bidi-font-style:&#xD;
normal"&gt;Lactarius deliciosus&lt;/i&gt;, has been synthesised starting from&#xD;
6-amino-2,2-dimethylchroman-4-one &lt;b style="mso-bidi-font-weight:normal"&gt;3,&lt;/b&gt;&#xD;
which in turn, is prepared from paracetamol &lt;i style="mso-bidi-font-style:normal"&gt;via&#xD;
&lt;/i&gt;the known intermediates. The amino compound &lt;b style="mso-bidi-font-weight:&#xD;
normal"&gt;3&lt;/b&gt; is then converted to the iodo compound &lt;b style="mso-bidi-font-weight:&#xD;
normal"&gt;4, &lt;/b&gt;followed by formylation of the latter using N-formylpiperidine&#xD;
to provide, efficiently, the natural product &lt;b style="mso-bidi-font-weight:&#xD;
normal"&gt;1 &lt;/b&gt;in good yield.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1761-1762</description>
  </item>
  <item rdf:about="http://nopr.niscair.res.in/handle/123456789/15199">
    <title>&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:WordDocument&gt; &lt;w:View&gt;Normal&lt;/w:View&gt; &lt;w:Zoom&gt;0&lt;/w:Zoom&gt; &lt;w:PunctuationKerning/&gt; &lt;w:ValidateAgainstSchemas/&gt; &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt; &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt; &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt; &lt;w:Compatibility&gt; &lt;w:BreakWrappedTables/&gt; &lt;w:SnapToGridInCell/&gt; &lt;w:WrapTextWithPunct/&gt; &lt;w:UseAsianBreakRules/&gt; &lt;w:DontGrowAutofit/&gt; &lt;/w:Compatibility&gt; &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt; &lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;span style="font-size:12.0pt;font-family: "Times New Roman";mso-fareast-font-family:"Times New Roman";mso-ansi-language: EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA" lang="EN-GB"&gt;QSAR analysis on inhibitors of human dihydroorotate dehydrogenase &lt;br&gt; (&lt;i style="mso-bidi-font-style:normal"&gt;h&lt;/i&gt;DHODH): The aryl carboxylic acid amide derivatives&lt;/span&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:LatentStyles DefLockedState="false" LatentStyleCount="156"&gt; &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt; /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;} &lt;/style&gt; &lt;![endif]--&gt;</title>
    <link>http://nopr.niscair.res.in/handle/123456789/15199</link>
    <description>Title: &lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:WordDocument&gt; &lt;w:View&gt;Normal&lt;/w:View&gt; &lt;w:Zoom&gt;0&lt;/w:Zoom&gt; &lt;w:PunctuationKerning/&gt; &lt;w:ValidateAgainstSchemas/&gt; &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt; &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt; &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt; &lt;w:Compatibility&gt; &lt;w:BreakWrappedTables/&gt; &lt;w:SnapToGridInCell/&gt; &lt;w:WrapTextWithPunct/&gt; &lt;w:UseAsianBreakRules/&gt; &lt;w:DontGrowAutofit/&gt; &lt;/w:Compatibility&gt; &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt; &lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;span style="font-size:12.0pt;font-family: "Times New Roman";mso-fareast-font-family:"Times New Roman";mso-ansi-language: EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA" lang="EN-GB"&gt;QSAR analysis on inhibitors of human dihydroorotate dehydrogenase &lt;br&gt; (&lt;i style="mso-bidi-font-style:normal"&gt;h&lt;/i&gt;DHODH): The aryl carboxylic acid amide derivatives&lt;/span&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:LatentStyles DefLockedState="false" LatentStyleCount="156"&gt; &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt; /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;} &lt;/style&gt; &lt;![endif]--&gt;
&lt;br/&gt;
&lt;br/&gt;Authors: Vyas, Vivek K; Ghate, Manjunath
&lt;br/&gt;
&lt;br/&gt;Abstract: Structural and&#xD;
physicochemical requirements of aryl carboxylic acid amide derivatives for the&#xD;
inhibition of &lt;span style="mso-bidi-font-style:italic"&gt;human d&lt;span style="mso-bidi-font-weight:bold"&gt;ihydroorotate dehydrogenase (&lt;i style="mso-bidi-font-style:normal"&gt;h&lt;/i&gt;DHODH) are explored in this QSAR study.&#xD;
The calculated molecular descriptors (electronic and thermodynamic) have been&#xD;
used to derive QSAR models between &lt;i style="mso-bidi-font-style:normal"&gt;h&lt;/i&gt;DHODH&#xD;
inhibitory activity and structural properties. The best model for prediction of&#xD;
&lt;i style="mso-bidi-font-style:normal"&gt;h&lt;/i&gt;DHODH inhibitory activity is obtained&#xD;
by applying sequential multiple linear regression (SMLR) analysis.  &lt;span style="mso-bidi-font-weight:bold"&gt;Regression&#xD;
coefficient of all the descriptors is significant at more than 99% and statistically&#xD;
significant model with r&lt;sup&gt;2 &lt;/sup&gt;&gt; 0.87 is obtained. Selected QSAR model&#xD;
emphasized the importance of logP, &lt;span style="mso-bidi-font-weight:bold"&gt;torsion&#xD;
energy (Et), &lt;span style="mso-bidi-font-weight:bold"&gt;1,4-dihedral van&#xD;
der Waals interaction (1,4-VDWE) and &lt;span style="mso-bidi-font-weight:&#xD;
bold"&gt;electronic descriptor&lt;b&gt; &lt;/b&gt;like&lt;b&gt; &lt;/b&gt;lowest unoccupied molecular&#xD;
orbital (LUMO) on &lt;i style="mso-bidi-font-style:normal"&gt;h&lt;/i&gt;DHODH inhibitory&#xD;
activity. Results of QSAR analysis show that logP and LUMO are the principle&#xD;
descriptors for inhibition of &lt;i style="mso-bidi-font-style:normal"&gt;h&lt;/i&gt;DHODH.&#xD;
QSAR model has also been tested successfully for internal (q&lt;sup&gt;2 &lt;/sup&gt;&gt;&#xD;
0.753) and external (r&lt;sup&gt;2&lt;/sup&gt;&lt;sub&gt; pred&lt;/sub&gt;&lt;sup&gt; &lt;/sup&gt;&gt; 0.621)&#xD;
validation criteria. It is believed that the results of this study will&#xD;
be helpful in the design of more potent and selective &lt;i style="mso-bidi-font-style:&#xD;
normal"&gt;h&lt;/i&gt;DHODH inhibitors.&#xD;
&#xD;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
&lt;br/&gt;
&lt;br/&gt;Page(s): 1749-1760</description>
  </item>
  <item rdf:about="http://nopr.niscair.res.in/handle/123456789/15198">
    <title>&lt;span style="font-size:12.0pt;font-family: "Times New Roman";mso-fareast-font-family:"Times New Roman";mso-ansi-language: EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA" lang="EN-GB"&gt;A novel alkaloid, four alkaloid precursors and a coumarin from &lt;i style="mso-bidi-font-style: normal"&gt;Feronia limonia&lt;/i&gt;&lt;/span&gt;</title>
    <link>http://nopr.niscair.res.in/handle/123456789/15198</link>
    <description>Title: &lt;span style="font-size:12.0pt;font-family: "Times New Roman";mso-fareast-font-family:"Times New Roman";mso-ansi-language: EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA" lang="EN-GB"&gt;A novel alkaloid, four alkaloid precursors and a coumarin from &lt;i style="mso-bidi-font-style: normal"&gt;Feronia limonia&lt;/i&gt;&lt;/span&gt;
&lt;br/&gt;
&lt;br/&gt;Authors: Pitchai, P; Ulagi, R; Mohan, P S; Gengan, R M
&lt;br/&gt;
&lt;br/&gt;Abstract: A new quinoline alkaloid&#xD;
has been isolated from the flowers of &lt;i style="mso-bidi-font-style:normal"&gt;Feronia&lt;/i&gt;&#xD;
&lt;i style="mso-bidi-font-style:normal"&gt;limonia&lt;/i&gt; along with four alkaloid&#xD;
precursors, one coumarin, a known steroid stigmasterol and &lt;i style="mso-bidi-font-style:&#xD;
normal"&gt;p&lt;/i&gt;-coumaric acid. The structures of compounds have been elucidated&#xD;
on the basis of spectroscopic data and comparison with the literature.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1771-1775</description>
  </item>
  <item rdf:about="http://nopr.niscair.res.in/handle/123456789/15197">
    <title>An improved and scalable process for the synthesis of a key intermediate for Etodolac, a non-steroidal anti-inflammatory drug</title>
    <link>http://nopr.niscair.res.in/handle/123456789/15197</link>
    <description>Title: An improved and scalable process for the synthesis of a key intermediate for Etodolac, a non-steroidal anti-inflammatory drug
&lt;br/&gt;
&lt;br/&gt;Authors: Sekharayya, M Chandra; Narayana, G Venkata; Nigam, Satish; Madhusudhan, G
&lt;br/&gt;
&lt;br/&gt;Abstract: An improved and scalable&#xD;
method is developed for the synthesis of 7-ethyltryptophol, a key intermediate&#xD;
for Etodolac, a non-steroidal anti-inflammatory drug (NSAID) starting from&#xD;
commercially available 2-ethylphenyl hydrazine and dihydrofuran with H&lt;sub&gt;2&lt;/sub&gt;SO&lt;sub&gt;4&lt;/sub&gt;&#xD;
as a catalyst in &lt;i style="mso-bidi-font-style:normal"&gt;N&lt;/i&gt;,&lt;i style="mso-bidi-font-style:normal"&gt;N&lt;/i&gt;-dimethylacetamide (DMAc)-H&lt;sub&gt;2&lt;/sub&gt;O&#xD;
(1:1) as a solvent in 69% yield. The method is easy, inexpensive and&#xD;
reproducible and the process is clean, high yielding and operationally simple.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1763-1766</description>
  </item>
</rdf:RDF>

